These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35378064)

  • 1. The impact of diagnostic stewardship interventions on Clostridiodes difficile test ordering practices and results.
    Khuvis J; Alsoubani M; Mae Rodday A; Doron S
    Clin Biochem; 2023 Jul; 117():23-29. PubMed ID: 35378064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset
    McCormick WL; Jackson G; Andrea SB; Whitehead V; Chargualaf TL; Touzard-Romo F
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):106-109. PubMed ID: 37424227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Mandatory Infectious Disease Specialist Approval on Hospital-Onset Clostridioides difficile Infection Rates and Testing Appropriateness.
    Lin MY; Stein BD; Kothadia SM; Blank S; Schoeny ME; Tomich A; Hayden MK; Segreti J
    Clin Infect Dis; 2023 Aug; 77(3):346-350. PubMed ID: 37157903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of an electronic medical record nudge on reducing testing for hospital-onset
    Howard-Anderson JR; Sexton ME; Robichaux C; Wiley Z; Varkey JB; Suchindran S; Albrecht B; Ashley Jones K; Fridkin SK; Jacob JT
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):411-417. PubMed ID: 32036798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study.
    Christensen AB; Barr VO; Martin DW; Anderson MM; Gibson AK; Hoff BM; Sutton SH; Widmaier V; Salim AA; Silkaitis C; Qi C; Zembower TR; Postelnick MJ; Rhodes NJ
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):269-275. PubMed ID: 30786942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.
    Schultz K; Sickbert-Bennett E; Marx A; Weber DJ; DiBiase LM; Campbell-Bright S; Bode LE; Baker M; Belhorn T; Buchanan M; Goldbach S; Harden J; Hoke E; Huenniger B; Juliano JJ; Langston M; Ritchie H; Rutala WA; Smith J; Summerlin-Long S; Teal L; Gilligan P
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29997201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
    Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
    Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
    Cook PP; Nichols S; Coogan M; Opera J; DeHart M
    Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In pursuit of the holy grail: Improving
    Karlovich NS; Sata SS; Griffith B; Coop A; Kalu IC; Engemann JJ; Seidelman J; Turner NA; Polage CR; Smith BA; Lewis SS
    Infect Control Hosp Epidemiol; 2022 Jul; 43(7):840-847. PubMed ID: 34085622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections.
    Kang M; Abeles SR; El-Kareh R; Taplitz RA; Nyheim E; Reed SL; Jenkins IH; Seymann GB; Myers FE; Torriani FJ;
    Jt Comm J Qual Patient Saf; 2020 Aug; 46(8):457-463. PubMed ID: 32576438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an electronic smart order-set for diagnostic stewardship of Clostridiodes difficile infection (CDI) in a community healthcare system in South Florida.
    Eckardt P; Guran R; Jalal AT; Krishnaswamy S; Samuels S; Canavan K; Martinez EA; Desai A; Miller N; Cano Cevallos EJ
    Am J Infect Control; 2024 Aug; 52(8):893-899. PubMed ID: 38935020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-step algorithm-based Clostridioides difficile testing as a tool for antibiotic stewardship.
    Dbeibo L; Lucky CW; Fadel WF; Sadowski J; Beeler C; Kelley K; Williams J; Webb D; Kara A
    Clin Microbiol Infect; 2023 Jun; 29(6):798.e1-798.e4. PubMed ID: 36804907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis.
    Lee HS; Plechot K; Gohil S; Le J
    Infect Dis Ther; 2021 Jun; 10(2):687-697. PubMed ID: 33770398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
    Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
    Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
    Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential underreporting of treated patients using a
    Guh AY; Fridkin S; Goodenough D; Winston LG; Johnston H; Basiliere E; Olson D; Wilson CD; Watkins JJ; Korhonen L; Gerding DN
    Infect Control Hosp Epidemiol; 2024 May; 45(5):590-598. PubMed ID: 38268440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
    Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
    J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.